Literature DB >> 6306100

Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies.

P Rosenthal, I J Rimm, T Umiel, J D Griffin, R Osathanondh, S F Schlossman, L M Nadler.   

Abstract

Lymphoid and myeloid cells isolated from second trimester fetal lymphoid organs were characterized by utilizing a panel of monoclonal antibodies that define human lineage-restricted, differentiation, histocompatibility, and activation antigens. At distinct gestational stages, the appearance of morphologically identifiable lymphoid and myeloid cells paralleled the appearance of cells expressing definable lymphoid and myeloid antigens. The proportion of cells in fetal liver, bone marrow, and spleen that expressed histocompatibility, myeloid, and B cell antigens increased with fetal maturation. In contrast, even the earliest fetal thymuses studied were of a phenotype no different than that seen during later stages of ontogeny. Although the cellular lineage of most fetal hematopoietic cells could be identified by this panel of reagents, a considerable number of fetal liver and bone marrow cells did not express any of these antigens, suggesting the possibility that they might represent early hematopoietic progenitor cells. These studies support the notion that the adult cellular phenotype is the result of both an orderly acquisition of differentiation antigens and the migration of these primitive cellular populations to specific fetal organs. Identification of hematopoietic progenitors in fetal tissues may facilitate the identification and isolation of early lymphoid and myeloid progenitor cells in adults.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306100

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Gene transfer approaches to the lysosomal storage disorders.

Authors:  J A Barranger; E O Rice; W P Swaney
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 2.  Early embryonal/fetal lymphopoietic ontogeny and leukemogenesis.

Authors:  G Prindull
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

Review 3.  Ontogeny of the human thymus during fetal development.

Authors:  D F Lobach; B F Haynes
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

4.  Haemopoiesis in human fetal and embryonic liver. Immunohistochemical determination in B5-fixed paraffin-embedded tissues.

Authors:  W Timens; W A Kamps; T Rozeboom-Uiterwijk; S Poppema
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes.

Authors:  T F Tedder; M Streuli; S F Schlossman; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  Fetal and neonatal development of human spleen: an immunohistological study.

Authors:  W Timens; T Rozeboom; S Poppema
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

7.  Variability in B cell maturation and differentiation in X-linked agammaglobulinemia.

Authors:  F E Leickley; R Buckley
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

8.  The development of gut associated lymphoid tissue in the terminal ileum of fetal human intestine.

Authors:  J Spencer; T T MacDonald; T Finn; P G Isaacson
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

9.  B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

Authors:  L M Nadler; S J Korsmeyer; K C Anderson; A W Boyd; B Slaughenhoupt; E Park; J Jensen; F Coral; R J Mayer; S E Sallan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies.

Authors:  Gadi Gazit Bornstein; Christophe Quéva; Mohammad Tabrizi; Anne van Abbema; Carlos Chavez; Ping Wang; Orit Foord; Kiran Ahluwalia; Naomi Laing; Sandhya Raja; Shenghua Wen; Larry L Green; Xiaodong Yang; Carl Webster; Ross Stewart; David Blakey
Journal:  Invest New Drugs       Date:  2009-07-21       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.